A Phase 1, Open-Label, Single-Injection, Dose-Escalation Study of the Safety and Tolerability Following Intravenous Administration of CRS-100, a Live-Attenuated Strain of Listeria Monocytogens, to Adult Subjects with Carcinoma Refractory to standard Treatment (or for whom no Standard Treatment is Available) and who Additionally Have Liver Mesastases that Represent a Predominant Portion of the Total Tumor Burden

Principal Investigator: Dr. Anna Pavlick

Contact # (212)731-5431 Juliet Escalon RN

Location(s) GCRC/Bellevue Inpatient

Shift(s) Evenings/Nights, Saturday Days

 

A Pilot Study of Aerosol Interferon-gamma Treatment in Idiopathic Pulmonary Fibrosis (IPF)

Principal Investigator: Dr. Rany Condos

Contact # 263-6837

Location(s) GCRC/Bellevue Outpatient

Shift(s) Days

 

Principal Investigators: Dr. David Naidich

Contact # 263-3944

Location(s) Tisch

Shifts(s) Saturday Days

 

For More Information Contact:

Ellie DeCandia, R.N. MA CCRC Nurse Manager
General Clinical Research Center
NYU/Bellevue 8East 20
212-263-6411
Email: decane01@gcrc.med.nyu.edu

Catherine Bing is interested in interning for research (volunteer) contact #347-782-1465